Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000899243-19-024776

SVP, COO & CFO acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP, COO & CFO 2019-10-01 Grant or award +75,000 227,872 D
Derivatives
Labrucherie Gil M SVP, COO & CFO 2019-10-01 Grant or award · Stock Option +150,000 150,000 D
Loading xslF345X03/doc4.xml…